Significant inverse association of equol-producer status with coronary artery calcification but not dietary isoflavones in healthy Japanese men

Vasudha Ahuja, Katsuyuki Miura, Abhishek Vishnu, Akira Fujiyoshi, Rhobert Evans, Maryam Zaid, Naoko Miyagawa, Takashi Hisamatsu, Aya Kadota, Tomonori Okamura, Hirotsugu Ueshima, Akira Sekikawa

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Equol, a metabolite of the dietary isoflavone daidzein, is produced by the action of gut bacteria in some individuals who are termed as equol-producers. It is proposed to have stronger atheroprotective properties than dietary isoflavones. We examined a cross-sectional association of dietary isoflavones and equol-producer status with coronary artery calcification (CAC), a biomarker of coronary atherosclerosis, among men in Japan. A population-based sample of 272 Japanese men aged 40-49 years recruited from 2004 to 2007 was examined for serum isoflavones, serum equol, CAC and other factors. Equol-producers were classified as individuals having a serum level of equol >83 nm. The presence of CAC was defined as a coronary Ca score ≥10 Agatston units. The associations of dietary isoflavones and equol-producers with CAC were analysed using multiple logistic regression. The median of dietary isoflavones, equol and CAC were 512·7 (interquartile range (IQR) 194·1, 1170·0), 9·1 (IQR 0·10, 33·1) and 0·0 (IQR 0·0, 1·0) nm, respectively. Prevalence of CAC and equol-producers was 9·6 and 16·0 %, respectively. Dietary isoflavones were not significantly associated with CAC. After multivariable adjustment, the OR for the presence of CAC in equol-producers compared with equol non-producers was 0·10 (95 % CI 0·01, 0·90, P<0·04). Equol-producers had significantly lower CAC than equol non-producers, but there was no significant association between dietary isoflavones and CAC, suggesting that equol may be a key factor for atheroprotective properties of isoflavones in Japanese men. This finding must be confirmed in larger studies or clinical trials of equol that is now available as a dietary supplement.

Original languageEnglish
Pages (from-to)260-266
Number of pages7
JournalBritish Journal of Nutrition
Volume117
Issue number2
DOIs
Publication statusPublished - 2017 Jan 28

Fingerprint

Equol
Isoflavones
Coronary Vessels
Serum

Keywords

  • Coronary artery calcification
  • Equol-producers
  • Isoflavones
  • Japanese
  • Men

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Nutrition and Dietetics

Cite this

Significant inverse association of equol-producer status with coronary artery calcification but not dietary isoflavones in healthy Japanese men. / Ahuja, Vasudha; Miura, Katsuyuki; Vishnu, Abhishek; Fujiyoshi, Akira; Evans, Rhobert; Zaid, Maryam; Miyagawa, Naoko; Hisamatsu, Takashi; Kadota, Aya; Okamura, Tomonori; Ueshima, Hirotsugu; Sekikawa, Akira.

In: British Journal of Nutrition, Vol. 117, No. 2, 28.01.2017, p. 260-266.

Research output: Contribution to journalArticle

Ahuja, V, Miura, K, Vishnu, A, Fujiyoshi, A, Evans, R, Zaid, M, Miyagawa, N, Hisamatsu, T, Kadota, A, Okamura, T, Ueshima, H & Sekikawa, A 2017, 'Significant inverse association of equol-producer status with coronary artery calcification but not dietary isoflavones in healthy Japanese men', British Journal of Nutrition, vol. 117, no. 2, pp. 260-266. https://doi.org/10.1017/S000711451600458X
Ahuja, Vasudha ; Miura, Katsuyuki ; Vishnu, Abhishek ; Fujiyoshi, Akira ; Evans, Rhobert ; Zaid, Maryam ; Miyagawa, Naoko ; Hisamatsu, Takashi ; Kadota, Aya ; Okamura, Tomonori ; Ueshima, Hirotsugu ; Sekikawa, Akira. / Significant inverse association of equol-producer status with coronary artery calcification but not dietary isoflavones in healthy Japanese men. In: British Journal of Nutrition. 2017 ; Vol. 117, No. 2. pp. 260-266.
@article{3b3f237b9db2427b993de88637ade2b8,
title = "Significant inverse association of equol-producer status with coronary artery calcification but not dietary isoflavones in healthy Japanese men",
abstract = "Equol, a metabolite of the dietary isoflavone daidzein, is produced by the action of gut bacteria in some individuals who are termed as equol-producers. It is proposed to have stronger atheroprotective properties than dietary isoflavones. We examined a cross-sectional association of dietary isoflavones and equol-producer status with coronary artery calcification (CAC), a biomarker of coronary atherosclerosis, among men in Japan. A population-based sample of 272 Japanese men aged 40-49 years recruited from 2004 to 2007 was examined for serum isoflavones, serum equol, CAC and other factors. Equol-producers were classified as individuals having a serum level of equol >83 nm. The presence of CAC was defined as a coronary Ca score ≥10 Agatston units. The associations of dietary isoflavones and equol-producers with CAC were analysed using multiple logistic regression. The median of dietary isoflavones, equol and CAC were 512·7 (interquartile range (IQR) 194·1, 1170·0), 9·1 (IQR 0·10, 33·1) and 0·0 (IQR 0·0, 1·0) nm, respectively. Prevalence of CAC and equol-producers was 9·6 and 16·0 {\%}, respectively. Dietary isoflavones were not significantly associated with CAC. After multivariable adjustment, the OR for the presence of CAC in equol-producers compared with equol non-producers was 0·10 (95 {\%} CI 0·01, 0·90, P<0·04). Equol-producers had significantly lower CAC than equol non-producers, but there was no significant association between dietary isoflavones and CAC, suggesting that equol may be a key factor for atheroprotective properties of isoflavones in Japanese men. This finding must be confirmed in larger studies or clinical trials of equol that is now available as a dietary supplement.",
keywords = "Coronary artery calcification, Equol-producers, Isoflavones, Japanese, Men",
author = "Vasudha Ahuja and Katsuyuki Miura and Abhishek Vishnu and Akira Fujiyoshi and Rhobert Evans and Maryam Zaid and Naoko Miyagawa and Takashi Hisamatsu and Aya Kadota and Tomonori Okamura and Hirotsugu Ueshima and Akira Sekikawa",
year = "2017",
month = "1",
day = "28",
doi = "10.1017/S000711451600458X",
language = "English",
volume = "117",
pages = "260--266",
journal = "British Journal of Nutrition",
issn = "0007-1145",
publisher = "Cambridge University Press",
number = "2",

}

TY - JOUR

T1 - Significant inverse association of equol-producer status with coronary artery calcification but not dietary isoflavones in healthy Japanese men

AU - Ahuja, Vasudha

AU - Miura, Katsuyuki

AU - Vishnu, Abhishek

AU - Fujiyoshi, Akira

AU - Evans, Rhobert

AU - Zaid, Maryam

AU - Miyagawa, Naoko

AU - Hisamatsu, Takashi

AU - Kadota, Aya

AU - Okamura, Tomonori

AU - Ueshima, Hirotsugu

AU - Sekikawa, Akira

PY - 2017/1/28

Y1 - 2017/1/28

N2 - Equol, a metabolite of the dietary isoflavone daidzein, is produced by the action of gut bacteria in some individuals who are termed as equol-producers. It is proposed to have stronger atheroprotective properties than dietary isoflavones. We examined a cross-sectional association of dietary isoflavones and equol-producer status with coronary artery calcification (CAC), a biomarker of coronary atherosclerosis, among men in Japan. A population-based sample of 272 Japanese men aged 40-49 years recruited from 2004 to 2007 was examined for serum isoflavones, serum equol, CAC and other factors. Equol-producers were classified as individuals having a serum level of equol >83 nm. The presence of CAC was defined as a coronary Ca score ≥10 Agatston units. The associations of dietary isoflavones and equol-producers with CAC were analysed using multiple logistic regression. The median of dietary isoflavones, equol and CAC were 512·7 (interquartile range (IQR) 194·1, 1170·0), 9·1 (IQR 0·10, 33·1) and 0·0 (IQR 0·0, 1·0) nm, respectively. Prevalence of CAC and equol-producers was 9·6 and 16·0 %, respectively. Dietary isoflavones were not significantly associated with CAC. After multivariable adjustment, the OR for the presence of CAC in equol-producers compared with equol non-producers was 0·10 (95 % CI 0·01, 0·90, P<0·04). Equol-producers had significantly lower CAC than equol non-producers, but there was no significant association between dietary isoflavones and CAC, suggesting that equol may be a key factor for atheroprotective properties of isoflavones in Japanese men. This finding must be confirmed in larger studies or clinical trials of equol that is now available as a dietary supplement.

AB - Equol, a metabolite of the dietary isoflavone daidzein, is produced by the action of gut bacteria in some individuals who are termed as equol-producers. It is proposed to have stronger atheroprotective properties than dietary isoflavones. We examined a cross-sectional association of dietary isoflavones and equol-producer status with coronary artery calcification (CAC), a biomarker of coronary atherosclerosis, among men in Japan. A population-based sample of 272 Japanese men aged 40-49 years recruited from 2004 to 2007 was examined for serum isoflavones, serum equol, CAC and other factors. Equol-producers were classified as individuals having a serum level of equol >83 nm. The presence of CAC was defined as a coronary Ca score ≥10 Agatston units. The associations of dietary isoflavones and equol-producers with CAC were analysed using multiple logistic regression. The median of dietary isoflavones, equol and CAC were 512·7 (interquartile range (IQR) 194·1, 1170·0), 9·1 (IQR 0·10, 33·1) and 0·0 (IQR 0·0, 1·0) nm, respectively. Prevalence of CAC and equol-producers was 9·6 and 16·0 %, respectively. Dietary isoflavones were not significantly associated with CAC. After multivariable adjustment, the OR for the presence of CAC in equol-producers compared with equol non-producers was 0·10 (95 % CI 0·01, 0·90, P<0·04). Equol-producers had significantly lower CAC than equol non-producers, but there was no significant association between dietary isoflavones and CAC, suggesting that equol may be a key factor for atheroprotective properties of isoflavones in Japanese men. This finding must be confirmed in larger studies or clinical trials of equol that is now available as a dietary supplement.

KW - Coronary artery calcification

KW - Equol-producers

KW - Isoflavones

KW - Japanese

KW - Men

UR - http://www.scopus.com/inward/record.url?scp=85013237620&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85013237620&partnerID=8YFLogxK

U2 - 10.1017/S000711451600458X

DO - 10.1017/S000711451600458X

M3 - Article

C2 - 28205492

AN - SCOPUS:85013237620

VL - 117

SP - 260

EP - 266

JO - British Journal of Nutrition

JF - British Journal of Nutrition

SN - 0007-1145

IS - 2

ER -